open access

Vol 23, No 6 (2016)
CLINICAL CARDIOLOGY Original articles
Published online: 2016-11-30
Get Citation

Levosimendan accelerates recovery in patients with takotsubo cardiomyopathy

Mehmet Yaman, Ugur Arslan, Ahmet Kaya, Aytac Akyol, Fatih Ozturk, Yunus Emre Okudan, Adil Bayramoglu, Osman Bektas
DOI: 10.5603/CJ.a2016.0100
·
Pubmed: 27910084
·
Cardiol J 2016;23(6):610-615.

open access

Vol 23, No 6 (2016)
CLINICAL CARDIOLOGY Original articles
Published online: 2016-11-30

Abstract

Background: The aim of this study was to determine the efficacy and safety of levosimendan
in takotsubo cardiomyopathy (TC).
Methods: The study was conducted in a retrospective design and 42 consecutive patients were enrolled in 6 cardiovascular centers in Turkey. The records of TC patients having left ventricular ejection fraction (LVEF) £ 35% were examined at admission, discharge and recovery period including their clinical and echocardiographic data.
Results: Of these 42 TC patients, 17 were treated with loading dose and i.v. infusion of levosimendan (group 1) and 25 were treated without levosimendan (group 2). Echocardiographic findings at admission and at discharge were similar and no serious complications were observed in either group. However recovery period including the interval of 50% increase in LVEF, time to achieve the baseline troponin values and hospitalization were significantly lower
in patients taking levosimendan.
Conclusions: This is the first study using loading dose and subsequent continuous intravenous administration of levosimendan demonstrating accelerated recovery in patients with TC.

Abstract

Background: The aim of this study was to determine the efficacy and safety of levosimendan
in takotsubo cardiomyopathy (TC).
Methods: The study was conducted in a retrospective design and 42 consecutive patients were enrolled in 6 cardiovascular centers in Turkey. The records of TC patients having left ventricular ejection fraction (LVEF) £ 35% were examined at admission, discharge and recovery period including their clinical and echocardiographic data.
Results: Of these 42 TC patients, 17 were treated with loading dose and i.v. infusion of levosimendan (group 1) and 25 were treated without levosimendan (group 2). Echocardiographic findings at admission and at discharge were similar and no serious complications were observed in either group. However recovery period including the interval of 50% increase in LVEF, time to achieve the baseline troponin values and hospitalization were significantly lower
in patients taking levosimendan.
Conclusions: This is the first study using loading dose and subsequent continuous intravenous administration of levosimendan demonstrating accelerated recovery in patients with TC.

Get Citation

Keywords

takotsubo cardiomyopathy; levosimendan; recovery; heart failure; stress cardiomyopathy

About this article
Title

Levosimendan accelerates recovery in patients with takotsubo cardiomyopathy

Journal

Cardiology Journal

Issue

Vol 23, No 6 (2016)

Pages

610-615

Published online

2016-11-30

DOI

10.5603/CJ.a2016.0100

Pubmed

27910084

Bibliographic record

Cardiol J 2016;23(6):610-615.

Keywords

takotsubo cardiomyopathy
levosimendan
recovery
heart failure
stress cardiomyopathy

Authors

Mehmet Yaman
Ugur Arslan
Ahmet Kaya
Aytac Akyol
Fatih Ozturk
Yunus Emre Okudan
Adil Bayramoglu
Osman Bektas

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl